# What Factors Affect Breast Cancer Neoadjuvant Chemotherapy Efficacy?

> **NCT03501394** · NA · UNKNOWN · sponsor: **University of Aberdeen** · enrollment: 25 (estimated)

## Conditions studied

- Breast Neoplasm Malignant Breast Tissue

## Interventions

- **OTHER:** Magnetic Resonance Imaging
- **OTHER:** Histopathological Analysis
- **OTHER:** Health Questionnaire

## Key facts

- **NCT ID:** NCT03501394
- **Lead sponsor:** University of Aberdeen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-02
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2018-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03501394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03501394, "What Factors Affect Breast Cancer Neoadjuvant Chemotherapy Efficacy?". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT03501394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*